[Xintian Pharmaceutical Co., Ltd.: formula granules have initially realized large-scale sales in the province] May 28, Xintian Pharmaceutical Co., Ltd. said in a survey that formula granules are an important business module of the company's new industrial layout. It is a new part of the company's future main product market, and it has initially realized large-scale sales in the province. According to the established plan, the intelligent production line of traditional Chinese medicine formula granules located in Guiyang production base is expected to be completed and put into trial production in June 2023, so as to make full production preparations for the national scale market of formula granules in the future. In terms of national standard variety filing, the company has completed nearly 200 variety filing, and plans to achieve the target of 300 national standard variety filing this year. In the future, it will follow the pace of the introduction of national standards and further accelerate the filing of national standards.